dual agonist glp-1 glucagon Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements

Frontiers

25.57

★★★★☆4.8 (126)

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism

28.15

★★★★★4.9 (98)

𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 ⁣ ⁣ Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong

28.97

★★★★★5.0 (157)

GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome

26.64

★★★★★4.7 (84)

Understanding GLP-1 receptor agonists and their impact on drug discovery

21.79

★★★★★4.9 (203)

Understanding diabetes meds can be tricky! 💊 I've broken down GLP-1 and Dual Agonist "incretin mimics" for you. These can help with insulin, digestion, and even weight loss. Learn more about Semaglutide,

24.84

★★★★★5.0 (176)

Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies

28.07

★★★★★4.8 (132)